Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-08

Clinical Trial Update: Effect of Human Thrombin With Gelatin Matrix on Perioperative Blood Loss in Scoliosis Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial update on the effect of human thrombin with gelatin matrix for perioperative blood loss in scoliosis surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Human thrombin with gelatin matrix (thrombin with gelatin matrix)

Snippet

Sponsor: Turku University Hospital | Conditions: Adolescent Idiopathic Scoliosis | Phase 4 | Status: COMPLETED